West China Second University Hospital
3 clinical trials · 3 recruiting · OTHER
Trials by West China Second University Hospital
RECRUITINGNCT07371182
Luvometinib in Pediatric SS-LCH With Special-site Single/Multifocal Bone Lesions
Langerhans cell histiocytosis (LCH) is the most common type of histiocytic disorder in children, affecting about 2.6 to 8.9 out of every million kids each year. It can look very...
Sponsor: West China Second University HospitalEnrolling: 6211 locations
Langerhans Cell Histiocytosis (LCH)
RECRUITINGNCT07431060
Modified LCH-III Regimen With or Without Luvometinib for Multisystem Pediatric Langerhans Cell Histiocytosis
Langerhans cell histiocytosis (LCH) is the most common histiocytic disorder in children, caused by excessive proliferation and accumulation of Langerhans cells (a type of immune...
Sponsor: West China Second University HospitalEnrolling: 12011 locations
Langerhans Cell Histiocytosis (LCH)
RECRUITINGNCT06881056
Peginterferon α-2b Injection for Aerosol Therapy in Pediatric Respiratory Syncytial Virus Pneumonia
This is a multicenter, randomized, open-label, parallel-controlled, prospective clinical study. It aims to evaluate the efficacy and safety of aerosolized Peginterferon α-2b...
Sponsor: West China Second University HospitalEnrolling: 902 locations
Respiratory Syncytial Virus (RSV)